摩根士丹利| ASML控股 NV（欧洲）：财报前瞻 Into the print（财报前瞻） ASML将于本周晚些时候（1 月 28 日周三）发布财报。 我们预计其订单量表现强劲，且我们的核心逻辑将开始兑现。 市场讨论焦点集中在 2027 年，但我们认为订单量将从 2025 年第四季度延续至 2026 年实现扩张。 摩根士丹利| ASML控股 NV（欧洲）：财报前瞻 Into the print（财报前瞻） ASML将于本周晚些时候（1 月 28 日周三）发布财报。 我们预计其订单量表现强劲，且我们的核心逻辑将开始兑现。 市场讨论焦点集中在 2027 年，但我们认为订单量将从 2025 年第四季度延续至 2026 年实现扩张。 我们重申 "增持"评级（首选标的），并维持 1400 欧元的目标价。 核心要点 2027 年盈利增长有望达到峰值，预计将交付 80 台 EUV 设备。 投资者在财报前关注的关键指标包括：2025 年第四季度订单量、2026 年营收增长、毛利率、EUV 及 DUV 营收增 长。 风险提示：2027 年 EUV 设备的需求可能触及峰值。 英特尔本季度的业绩，印证了我们 2026 财年的预测 ...

如何理解珠宝同店和金价的背离，以及如何用金价丈量本轮珠宝反弹高度【东财新消费｜零售】 珠宝并不是简单的越涨越买：黄金饰品对应的是大众/散户需求，逼空行情下量缩/观望是典型的特征，排队增加是 很正常的事情。 但伴随金价进一步上涨，局部抢购潮逐步将兴起，大约在1250元/g或复现25年2月抢购潮。 （本轮补库水位在去年11月，大约成本在900-1000，零售价多定于1500，若一口打折则约1400+，若金价逼近 1250，则一口价性价比绝对意义会超过计重） 1月目前行业同店较大幅度下滑，因金价抑制总需求/促销错期。 但环比伴随金价明显走强。 推荐排序：周生生、老铺、潮宏基、菜百股份，伴随金价上涨以及业绩催化，周生生将成为空间大、流动性改善 的入通简单题，保持第一推荐排序。 珠宝行业需求比做1250-1300元/g黄金虚值期权，并非击中1250期权才会上涨，在此阶段建议以金价为尺，进行灵 活的布局至2月第一周。 如何理解珠宝同店和金价的背离，以及如何用金价丈量本轮珠宝反弹高度【东财新消费｜零售】 珠宝并不是简单的越涨越买：黄金饰品对应的是大众/散户需求，逼空行情下量缩/观望是典型的特征，排队增加是 很正常的事情。 ...

Summary of Key Points from Conference Call Records Industry Overview - **Precious Metals and Non-Ferrous Metals**: Significant price movements observed in precious metals, particularly gold, which surged over 2% to exceed $5100 per ounce, indicating strong market demand and investor interest [1][2]. Core Insights and Arguments - **Gold Market Performance**: The spot price of gold increased by 2.29%, marking a daily rise of over $110, reflecting robust investor sentiment and market dynamics [1]. - **Tungsten Market Trends**: - The price of black tungsten concentrate rose by 11.43% to 536,000 CNY per ton, while ammonium paratungstate increased by 12.06% to 790,000 CNY per ton, indicating tightening supply conditions [2][4]. - Supply constraints are evident as mining production slows down due to reduced extraction quotas, leading to a tightening of market circulation [3]. - **Tin Market Dynamics**: - SHFE tin prices rose by 21.85% to 429,600 CNY per ton, and LME tin prices increased by 21.73% to $54,200 per ton, driven by supply pressures from geopolitical issues in major production areas [4][5]. Additional Important Content - **Biopharmaceutical Sector**: The outbreak of the Nipah virus in West Bengal, India, has raised concerns, with multiple healthcare workers infected, prompting urgent preventive measures in neighboring countries [6]. - **Space Photovoltaics**: - Elon Musk announced plans for SpaceX and Tesla to establish 100 GW of solar capacity in the U.S. within three years, which could significantly boost long-term demand for space photovoltaics [6]. - The commercial space sector is entering a new phase of large-scale deployment, with over 200,000 satellite constellation applications submitted in China [6]. - **Cloud Computing and AI**: AWS has raised its EC2 machine learning capacity block prices by approximately 15%, indicating rising operational costs in the cloud computing sector [7]. - **Oil and Gas Market**: Natural gas prices in the U.S. surged due to winter storms, with futures exceeding $6 per million British thermal units for the first time since 2022, reflecting supply-demand imbalances [7]. Stock Performance Highlights - **Top Gainers**: - In the precious metals sector, stocks such as Hunan Gold, Sichuan Gold, and China Gold saw significant price increases [2]. - In the tungsten sector, stocks like Xianglu Tungsten and Zhongtung High-tech performed well [4]. - In the biopharmaceutical sector, companies like Maike Biotech and Kaili Biotech experienced notable stock gains [6]. - **Market Activity**: The total trading volume in the Shanghai and Shenzhen markets approached 3.3 trillion CNY, reflecting increased market activity compared to the previous trading day [1].

Summary of Key Points from the Conference Call Company Overview - The conference call involved Tencent, a leading technology and entertainment conglomerate in China, discussing various aspects of its business operations and market dynamics. Core Insights and Arguments - **AI Investment**: Tencent has made significant investments in AI, which is highlighted as a key focus area for the company in the past year [1] - **Cloud Business Profitability**: The cloud business has achieved profitability, indicating a successful transition and growth in this segment [1] - **Gaming Business Strength**: Tencent's gaming business is described as "strong beyond measure," reflecting its dominant position in the gaming industry [1] - **Criticism of Doubao Phone**: Tencent's Chairman, Ma Huateng, expressed strong opposition to the Doubao phone's method of using external tools to record screens from mobile devices to the cloud, labeling it as "extremely unsafe and irresponsible" [1] Additional Important Content - **Broader Business Context**: The discussion also touched on various other Tencent businesses, including cloud services, gaming, document services, Tencent News, TME (Tencent Music Entertainment), and application distribution through App Store [1] - **Competitive Landscape**: The mention of the "takeout war" and "AI war" suggests a competitive environment in which Tencent is actively engaged, indicating ongoing strategic challenges and opportunities in the market [1]

【zx金属碳酸锂点评】锂价日内振幅14%，把握股票回调后的建仓机会 1、碳酸锂期货价盘中下跌14%，主要由于监管对多头指导，基本面并无实质性利空，持续看多锂价，建议关注股 票回调后的买入机会，推荐#盐湖股份、#中矿资源、#赣锋锂业、#盛新锂能。 2、国内供应端，上游春季检修即将开始，周度产量会进一步下滑。 海外供应端，3月之前非洲澳洲无新增供应到港，巴西Sigma锂矿出售尾 【zx金属碳酸锂点评】锂价日内振幅14%，把握股票回调后的建仓机会 海外供应端，3月之前非洲澳洲无新增供应到港，巴西Sigma锂矿出售尾精粉的品质较低，国内加工能力不足，鲜 有贸易商愿意接货，对国内供应影响有限。 3、储能电芯需求维持旺盛，终端电站的建设并无阻碍，降息背景利好收益率提升。 动力电池需求受益于单车带电量的大幅提高(12月69度电)，终端车销量下滑不影响电池厂排产稳定，2月电池排产 数据或成为需求端新的利多。 4、近期产业链库存仍维持极低水平，且结构已开始变化。 上游厂累库代表惜售情绪加重，下游找贸易商询价接货量大幅增加，库存从贸易商转移至下游。 临近春节，下游主动补库的意愿更强。 近期每次下跌都会推动下游采购量大幅提升，已经 ...

【中泰科技消费丨家电】董明珠卸任电子元器件公司职务 26年1月26日董明珠卸任全资子公司——珠海格力电子元器件有限公司的执行董事和法代职务，由方祥建继任。 方是公司副总，此前主管盾安、格力钛和零部件等2B业务。 #我们认为此次董总卸任是进一步让子公司放开手脚、发挥新生力量能力的标志。 我们梳理了23年以来董总卸任的3个子公司，包括电子元器 【中泰科技消费丨家电】董明珠卸任电子元器件公司职务 26年1月26日董明珠卸任全资子公司——珠海格力电子元器件有限公司的执行董事和法代职务，由方祥建继任。 方是公司副总，此前主管盾安、格力钛和零部件等2B业务。 #我们认为此次董总卸任是进一步让子公司放开手脚、发挥新生力量能力的标志。 我们梳理了23年以来董总卸任的3个子公司，包括电子元器件、集成电路和医疗装备。 ...

Summary of Key Points from the Conference Call Industry Overview - The data pertains to the Chinese stock market, specifically focusing on major indices such as 中证500 (CSI 500), 沪深300 (CSI 300), 上证50 (SSE 50), and 中证1000 (CSI 1000) [1] Core Insights and Arguments - 中证500 has seen a reduction in short positions by 2,074, resulting in a net short position of 13,017 [1] - 沪深300 has increased its short positions by 1,932, leading to a net short position of 12,756 [1] - 上证50 has reduced its short positions by 989, with a net short position of 4,441 [1] - 中证1000 has decreased its short positions by 1,099, resulting in a net short position of 32,976 [1] - 中信 has cumulatively reduced short positions by 2,230, with a total net short position of 63,190 [1] - Major players in the market have seen a reduction in short positions for 中证500 by 2,598, leading to a net short position of 39,436 [1] - For 沪深300, major players have increased short positions by 1,492, resulting in a net short position of 42,535 [1] - 上证50 has seen an increase in short positions by 928, with a net short position of 19,964 [1] - 中证1000 has experienced a reduction in short positions by 3,935, leading to a net short position of 51,536 [1] - Major players have cumulatively reduced short positions by 4,113, with a total net short position of 153,471 [1] Additional Important Information - The total trading volume across the three markets reached 32,810 billion, which is an increase of 1,627 billion compared to the previous trading day [1] - There was a net outflow of 1,216.26 billion from the main players [1] - The margin financing balance stands at 27,234.75 billion, which is a decrease of 14.38 billion from the previous trading day [1]

【西部大化工&新材料】苯胺价格持续上涨，供需格局向好，建议关注万华化学、扬农化工 ————————————- 事件：#苯胺价格持续上涨。 据百川盈孚，截至1月23日，苯胺库存量为4950吨，为24年以来最低水平，企业销售压力较小，挺价动力坚实。 2）需求端，本轮苯胺上涨主要受出口商入市补空单推动。 据百川盈孚，截至1月25日，苯胺行业均价8848元/吨，同比上周+3.85%，较25年12月10日的低点累计上涨1165元/ 吨(+15.2%)。 #成本支撑强劲，库存持续下降，企业挺价动力强 【西部大化工&新材料】苯胺价格持续上涨，供需格局向好，建议关注万华化学、扬农化工 ————————————- 事件：#苯胺价格持续上涨。 据百川盈孚，截至1月25日，苯胺行业均价8848元/吨，同比上周+3.85%，较25年12月10日的低点累计上涨1165元/ 吨(+15.2%)。 #成本支撑强劲，库存持续下降，企业挺价动力强。 1）供应端，整体现货偏紧，行业库存持续下降。 据隆众资讯，受前期多套装置计划外停机影响，12月中旬开始国内苯胺长期处于现货偏紧格局。 1月以来，出口商集中入市补空单，多数下游企业正常入市采购，推高 ...

Summary of Key Points from Conference Call Records Industry Overview - The pharmaceutical industry is experiencing mixed performance in the A-share market, with the Shanghai Composite Index closing at 4132.61 points, down 0.09%, and the Shenzhen Component Index at 14316.64 points, down 0.85% [1][1] - The Shenwan Pharmaceutical Industry Index closed at 8648.35 points, up 0.29%, while the Hang Seng Healthcare Index in Hong Kong closed at 4032.36 points, down 1.58% [1][1] Company-Specific Insights Performance Forecasts - **Guangji Pharmaceutical**: Expected net loss for 2025 is between 518 million to 399 million yuan, a significant increase from the previous year's loss of 295 million yuan [2][2] - **Yixin Pharmacy**: Projected net profit for 2025 is between 260 million to 330 million yuan, a substantial increase of 127.79% to 189.12% year-on-year [2][3] - **International Medicine**: Anticipated revenue drop to 4.06 billion to 4.08 billion yuan, a 15.7% decline, with net loss expected to widen to between 315 million to 295 million yuan [3][3] - **Weichip Bio**: Expected revenue of 910 million yuan, a 38.32% increase, with net profit turning positive at 53.46 million yuan, a significant improvement from a loss of 115 million yuan [3][3] - **Tonghua Dongbao**: Forecasted net profit of 1.242 billion yuan, recovering from a loss of 42.72 million yuan in the previous year [4][4] - **Meinuo Pharma**: Expected net profit between 100 million to 123 million yuan, a growth of 49.69% to 84.11% year-on-year [4][4] - **Sangfor Biopharma**: Projected revenue of 4.2 billion yuan, a significant increase of 251.76%, with net profit expected to reach 2.9 billion yuan, a 311.35% increase [4][5] - **Huahai Pharmaceutical**: Expected net profit to decline by 70% to 80%, with projections between 224 million to 335 million yuan [5][5] - **Dabo Medical**: Anticipated net profit between 580 million to 610 million yuan, a growth of 62.55% to 70.96% [5][5] Regulatory Approvals - **Hengrui Medicine**: Received clinical trial approval for SHR-1049 injection [2][2] - **Qianjin Pharmaceutical**: Obtained drug registration for aluminum magnesium carbonate chewable tablets [2][2] - **Wantai Bio**: Two-valent HPV vaccine passed WHO PQ periodic review [2][2] Market Trends - The A-share market shows volatility with significant fluctuations in stock performance, particularly in the pharmaceutical sector, indicating potential investment opportunities and risks [1][1] - The performance of individual companies varies widely, with some showing strong growth while others face significant losses, highlighting the need for careful analysis when considering investments in this sector [2][3][4][5]

Summary of Key Points from the Conference Call Industry Overview - The report focuses on the education industry, particularly the rise of leading companies New Oriental and TAL Education, driven by technological changes and demographic shifts [1]. Core Insights 1. **Rise of Dual Leaders in Education**: The expansion of the education market is propelled by technological transformation and changes in population structure, highlighting the synergy between these factors [1]. 2. **AI Empowerment in Education**: The integration of AI in education has shown significant improvements in quality and efficiency, indicating a clear commercial potential for AI+education [1]. 3. **Competitive Analysis of AI+Education**: The barriers within educational scenarios are well-defined, with a positive outlook for companies that demonstrate strong product capabilities and effective promotional strategies [1]. Investment Opportunities - Companies with rich vertical data and strong product capabilities to consider include: - DouShen Education - Rongxin Culture - Century Tianhong - Fenbi - TAL Education [2]. - Companies with high customer reach and promotional advantages include: - Southern Media - New Oriental - Zhongyuan Media - Wanxin Media - Urban Media - Quanta Education [2].